Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$10,000,000.00Target Investment:
$1,000,000.00
Skills
Education
Lists including Andy
Work Experience
2022
Board Observer and Investor
2022
2022
Board Director and Lead Investor
2022
2021
Board Director and Lead Investor
2021
Principal
2021
Leading investments in innovative biotechnology and healthcare companies. Focusing on long term investing out of a $8Bn AUM hedge fund to support companies through their entire life cycle (from early through crossover and public stages).
2018 - 2021
Investment Partner
2018 - 2021
Investing in early stage ventures at the frontier of biotech and engineering in therapeutics, diagnostics and tools. Seed and Series A Lead investments include Scribe Therapeutics, Insitro, Genesis Therapeutics, EQRx, Octant Biosciences, Tmunity, Nautilus, Earli, and several stealth seeds in the biotech space.
2018 - 2021
Investor and Board Observer
2018 - 2021
2018 - 2021
Board Observer
2018 - 2021
2018 - 2021
Investor
2018 - 2021
2018 - 2021
Investor
2018 - 2021
2018 - 2021
Board Observer
2018 - 2021